Park Place Capital Corp Has $257,000 Stake in Chemed Co. (NYSE:CHE)

Park Place Capital Corp increased its position in shares of Chemed Co. (NYSE:CHE) by 716.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 400 shares of the company’s stock after buying an additional 351 shares during the period. Park Place Capital Corp’s holdings in Chemed were worth $257,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. Wealth Alliance increased its holdings in Chemed by 3.0% during the fourth quarter. Wealth Alliance now owns 578 shares of the company’s stock worth $338,000 after buying an additional 17 shares during the last quarter. Legacy Wealth Asset Management LLC increased its holdings in Chemed by 0.9% during the fourth quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock worth $1,330,000 after buying an additional 21 shares during the last quarter. Signaturefd LLC increased its holdings in Chemed by 5.8% during the fourth quarter. Signaturefd LLC now owns 385 shares of the company’s stock worth $225,000 after buying an additional 21 shares during the last quarter. Ballentine Partners LLC increased its holdings in Chemed by 3.4% during the first quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after buying an additional 22 shares during the last quarter. Finally, Kestra Advisory Services LLC increased its holdings in Chemed by 3.8% during the third quarter. Kestra Advisory Services LLC now owns 634 shares of the company’s stock worth $329,000 after buying an additional 23 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $567.54, for a total value of $2,270,160.00. Following the completion of the sale, the chief executive officer now owns 108,549 shares of the company’s stock, valued at $61,605,899.46. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the sale, the director now owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the sale, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at approximately $61,605,899.46. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,784 shares of company stock valued at $3,240,053. 3.32% of the stock is owned by company insiders.

Chemed Price Performance

CHE stock opened at $539.54 on Tuesday. The company has a fifty day moving average price of $556.04 and a two-hundred day moving average price of $588.78. Chemed Co. has a one year low of $492.84 and a one year high of $654.62. The stock has a market cap of $8.17 billion, a price-to-earnings ratio of 29.04, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to the consensus estimate of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Research analysts anticipate that Chemed Co. will post 21.54 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th were given a $0.40 dividend. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.30%. Chemed’s payout ratio is presently 8.61%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on CHE shares. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Royal Bank of Canada reduced their price objective on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research report on Tuesday, May 21st.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.